Elevated RDW Correlated With Increased Mortality in COVID-19 Patients
Study authors assessed the association between elevated and increasing red blood cell distribution width and increased mortality risk in patients with COVID-19.
COVID19
Deferral of AVR for Severe Aortic Stenosis During COVID-19 Associated With Worsening Heart Failure
Patients with symptomatic severe aortic stenosis who had aortic valve replacement deferred vs expedited at the beginning of the COVID-19 pandemic were more likely to be hospitalized for valve-related symptoms or worsening heart failure.
Performance of 5 Immunoassays for SARS-CoV-2 Compared
A comparative assessment of 5 immunoassays for SARS-CoV-2 showed that these assays achieved sensitivity and specificity of at least 98%.
COVID-19 Pandemic Associated with Acute Stress, Depressive Symptoms in Residents of the United States
While the COVID-19 pandemic is a stress-inducing event, published empirical studies about mental health consequences are rare.
Decrease in Antibodies to SARS-CoV-2 Seen Over 60 Days Among Health Care Personnel
Investigators conducted a single-center study to evaluate the anti-SARS-CoV-2 antibodies at baseline and 60 days in health care personnel, who are at particular risk if antibodies level decline.
Pneumomediastinum May Increase Mortality in COVID-19 Pneumonia
Pneumomediastinum, although a rare phenomenon, is more prevalent in patients with COVID-19 compared with historical patients with adult respiratory distress syndrome.
Combination Antibody Therapy Reduces Viral Load, COVID-19 Hospitalizations
An interim analysis of the phase 2 study evaluated the combination therapy in recently diagnosed patients with mild to moderate COVID-19.
Methyl-Prednisolone Pulses May Improve COVID-19 Pneumonia Prognosis
Patients with severe COVID-19 pneumonia had improved prognosis after receiving a short course of methyl-prednisolone pulses during the second week of disease.
Trial Evaluating Anti-SARS-CoV-2 Hyperimmune Globulin Begins
The antibody solution is derived from plasma donated by healthy individuals who have recovered from COVID-19.
Antibody Therapy VIR-7831 Enters Phase 3 for Outpatient COVID-19 Treatment
The second part of the study will assess the efficacy and safety of a single intravenous infusion of VIR-7831 in approximately 1300 patients.
-
Loading...
-
Loading...
Next post in COVID19
